NYSE : AZN

AstraZeneca PLC — Financial statements

Healthcare · Drug Manufacturers - General · United Kingdom

Last price 174.4 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 270.72B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

AstraZeneca PLC (AZN) reported revenue of 62.38B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Operating Revenue62.38B58.74B54.07B45.81B44.35B37.42B
Revenue62.38B58.74B54.07B45.81B44.35B37.42B
Cost of Revenue11.37B10.75B9.64B8.04B8.64B12.01B
Gross Profit51.02B47.99B44.44B37.77B35.71B25.41B
Selling, General & Admin21.06B20.07B19.45B18.04B17.46B14.67B
Research & Development14.28B13.85B12.24B10.31B9.67B8.05B
Other Operating Expenses-420.00M-222.00M-190.00M-275.00M-231.00M-207.00M
Operating Expenses34.92B33.70B31.51B28.07B26.90B22.52B
Operating Income16.10B14.29B12.93B9.70B8.81B2.90B
Interest Expense-1.46B-1.36B-1.40B-1.22B-917.00M-776.00M
Interest & Investment Income352.00M360.00M345.00M301.00M81.00M43.00M
Earnings From Equity Investments-41.00M-7.00M-28.00M-12.00M-5.00M-64.00M
Currency Exchange Gain (Loss)-31.00M-31.00M-42.00M-34.00M-16.00M-20.00M
Other Non Operating Income (Expenses)-247.00M-247.00M-134.00M-292.00M-370.00M-478.00M
EBT Excluding Unusual Items14.67B13.00B11.67B8.44B7.58B1.60B
Merger & Restructuring Charges-690.00M-262.00M-1.15B-581.00M-4.20B-1.28B
Gain (Loss) on Sale of Investments100.00M776.00M
Gain (Loss) on Sale of Assets192.00M154.00M60.00M292.00M216.00M509.00M
Asset Writedown-713.00M-230.00M-1.57B-434.00M-241.00M-2.07B
Legal Settlements-218.00M-218.00M-48.00M-1.01B-789.00M-48.00M
Other Unusual Items-44.00M-44.00M-260.00M192.00M-69.00M248.00M
Pretax Income13.30B12.40B8.69B6.90B2.50B-265.00M
Income Tax Expense2.27B2.17B1.65B938.00M-792.00M-380.00M
Earnings From Continuing Operations11.03B10.23B7.04B5.96B3.29B115.00M
Minority Interest in Earnings-4.00M-8.00M-6.00M-6.00M-5.00M-3.00M
Net Income11.03B10.22B7.04B5.96B3.29B112.00M
Net Income to Common11.03B10.22B7.04B5.96B3.29B112.00M
Shares Outstanding (Basic)1.55B1.55B1.55B1.55B1.55B1.42B
Shares Outstanding (Diluted)1.56B1.56B1.56B1.56B1.56B1.43B
EPS (Basic)7.126.604.543.842.120.08
EPS (Diluted)7.066.544.503.812.110.08
Free Cash Flow10.21B11.77B9.94B8.98B8.72B4.87B
Free Cash Flow Per Share6.547.536.365.755.593.41
Dividend Per Share3.233.203.102.902.902.87
Gross Margin81.78%81.71%82.18%82.44%80.52%67.92%
Operating Margin25.80%24.33%23.91%21.17%19.87%7.74%
Profit Margin17.68%17.41%13.01%13.00%7.41%0.30%
Free Cash Flow Margin16.37%20.03%18.38%19.61%19.66%13.02%
EBITDA21.28B19.28B17.57B14.28B13.74B6.70B
EBITDA Margin34.11%32.82%32.49%31.16%30.99%17.91%
D&A For EBITDA5.18B4.99B4.64B4.58B4.93B3.80B
EBIT16.10B14.29B12.93B9.70B8.81B2.90B
EBIT Margin25.80%24.33%23.91%21.17%19.87%7.74%
Effective Tax Rate17.04%17.49%18.98%13.60%
Revenue as Reported62.38B58.74B54.07B45.81B44.35B37.42B

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents7.94B5.71B5.49B5.84B6.17B6.33B
Short-Term Investments230.00M64.00M53.00M
Trading Asset Securities8.00M37.00M20.00M14.00M16.00M
Cash & Short-Term Investments8.17B5.72B5.53B5.86B6.24B6.40B
Accounts Receivable14.74B10.24B8.30B8.41B7.21B6.03B
Other Receivables1.64B4.06B4.79B3.53B2.71B2.76B
Receivables16.38B14.30B13.09B11.94B9.92B8.79B
Inventory6.88B6.56B5.29B5.42B4.70B8.98B
Prepaid Expenses2.03B1.74B1.62B1.33B1.51B
Restricted Cash22.00M129.00M102.00M162.00M
Other Current Assets20.00M90.00M54.00M116.00M236.00M556.00M
Total Current Assets31.45B28.72B25.83B25.05B22.59B26.24B
Property, Plant & Equipment16.78B14.70B11.65B10.50B9.45B10.17B
Long-Term Investments2.94B2.52B1.90B1.68B1.14B1.26B
Goodwill21.16B21.24B21.02B20.05B19.82B20.00B
Other Intangible Assets38.15B37.85B37.18B38.09B39.31B42.39B
Long-Term Deferred Tax Assets6.66B5.82B5.35B4.72B3.26B4.33B
Other Long-Term Assets2.79B3.22B1.11B1.03B909.00M972.00M
Total Assets119.92B114.07B104.03B101.12B96.48B105.36B
Accounts Payable23.57B3.82B3.64B3.27B2.55B2.82B
Accrued Expenses19.30B16.09B15.85B13.51B12.36B
Short-Term Debt2.09B644.00M330.00M515.00M350.00M411.00M
Current Portion of Long-Term Debt2.88B2.54B2.06B5.60B5.92B2.25B
Current Portion of Leases445.00M382.00M339.00M271.00M228.00M233.00M
Current Income Taxes Payable1.62B1.08B1.41B1.58B896.00M916.00M
Current Unearned Revenue144.00M126.00M149.00M182.00M1.18B
Other Current Liabilities654.00M2.70B3.88B3.31B2.65B2.42B
Total Current Liabilities31.27B30.62B27.87B30.54B26.29B22.59B
Long-Term Debt26.57B24.71B26.62B22.40B23.91B29.72B
Long-Term Leases2.33B1.42B1.11B857.00M725.00M754.00M
Long-Term Unearned Revenue55.00M7.00M14.00M26.00M
Pension & Post-Retirement Benefits780.00M1.10B1.33B1.52B1.17B2.45B
Long-Term Deferred Tax Liabilities3.62B3.50B3.31B2.84B2.94B6.21B
Other Long-Term Liabilities3.54B3.94B2.93B3.78B4.37B4.33B
Total Liabilities68.11B65.36B63.16B61.95B59.42B66.08B
Common Stock388.00M388.00M388.00M388.00M387.00M387.00M
Additional Paid-In Capital35.29B35.27B35.23B35.19B35.16B35.13B
Retained Earnings14.07B12.60B7.23B4.52B3.12B3.64B
Comprehensive Income & Other1.99B414.00M-2.06B-949.00M-1.62B111.00M
Total Common Equity51.73B48.67B40.79B39.14B37.04B39.27B
Minority Interest86.00M52.00M85.00M23.00M21.00M19.00M
Shareholders' Equity51.81B48.72B40.87B39.17B37.06B39.29B
Total Liabilities & Equity119.92B114.07B104.03B101.12B96.48B105.36B
Total Debt34.33B29.70B30.46B29.65B31.14B33.36B
Net Cash (Debt)-26.16B-23.98B-24.93B-23.79B-24.89B-26.96B
Net Cash Per Share-16.75-15.35-15.95-15.23-15.96-18.90
Filing Date Shares Outstanding1.55B1.55B1.55B1.55B1.55B1.55B
Total Common Shares Outstanding1.55B1.55B1.55B1.55B1.55B1.55B
Working Capital181.00M-1.89B-2.04B-5.49B-3.70B3.65B
Book Value Per Share33.3531.3826.3025.2523.9025.34
Tangible Book Value-7.58B-10.42B-17.42B-18.99B-22.09B-23.12B
Tangible Book Value Per Share-4.88-6.72-11.23-12.25-14.25-14.92
Land7.24B6.58B6.47B5.44B6.38B
Machinery10.32B8.85B8.70B7.56B7.90B
Construction In Progress4.74B2.79B2.04B2.65B2.73B

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income11.03B10.22B7.04B5.96B3.29B112.00M
Depreciation & Amortization5.59B5.39B4.98B4.85B5.18B4.04B
Other Amortization236.00M236.00M200.00M280.00M292.00M311.00M
Loss (Gain) From Sale of Assets-193.00M-155.00M-60.00M-292.00M-216.00M-509.00M
Asset Writedown & Restructuring Costs726.00M243.00M1.62B456.00M226.00M2.43B
Loss (Gain) From Sale of Investments-776.00M
Loss (Gain) on Equity Investments41.00M7.00M28.00M12.00M5.00M64.00M
Stock-Based Compensation366.00M366.00M42.00M-71.00M27.00M45.00M
Other Operating Activities-1.63B-602.00M-1.09B-1.15B-2.75B-1.77B
Change in Accounts Receivable-1.73B-1.73B-1.62B-1.43B-1.35B-961.00M
Change in Inventory-755.00M-755.00M-131.00M-669.00M3.94B1.58B
Change in Accounts Payable1.35B1.35B862.00M2.39B1.17B1.41B
Operating Cash Flow13.23B14.57B11.86B10.35B9.81B5.96B
Capital Expenditures-3.02B-2.81B-1.92B-1.36B-1.09B-1.09B
Sale of Property, Plant & Equipment16.00M13.00M55.00M132.00M282.00M13.00M
Cash Acquisitions-1.16B-1.23B-3.78B-1.10B-1.03B-10.12B
Sale (Purchase) of Intangibles-3.89B-2.96B-2.54B-2.13B-1.03B-522.00M
Investment in Securities-227.00M-108.00M-133.00M-87.00M-143.00M605.00M
Other Investing Activities254.00M286.00M343.00M477.00M60.00M54.00M
Investing Cash Flow-8.04B-6.81B-7.98B-4.06B-2.96B-11.06B
Short-Term Debt Issued364.00M161.00M74.00M
Long-Term Debt Issued15.00M6.49B3.82B12.93B
Total Debt Issued5.41B379.00M6.49B3.98B74.00M12.93B
Short-Term Debt Repaid-31.00M-276.00M
Long-Term Debt Repaid-2.40B-4.97B-5.21B-1.51B-5.00B
Lease Payments-381.00M-372.00M-316.00M-268.00M-244.00M-240.00M
Total Debt Repaid-4.85B-2.40B-5.00B-5.21B-1.51B-5.28B
Net Debt Issued (Repaid)564.00M-2.02B1.49B-1.23B-1.44B7.65B
Issuance of Common Stock43.00M40.00M38.00M33.00M29.00M29.00M
Repurchase of Common Stock-776.00M-521.00M-81.00M
Common Dividends Paid-4.83B-4.85B-4.61B-4.49B-4.36B-3.86B
Other Financing Activities-346.00M-195.00M-840.00M-876.00M-1.05B-178.00M
Financing Cash Flow-5.35B-7.54B-4.00B-6.57B-6.82B3.65B
Foreign Exchange Rate Adjustments-12.00M46.00M-93.00M-60.00M-80.00M-62.00M
Net Cash Flow-163.00M269.00M-208.00M-346.00M-55.00M-1.51B
Free Cash Flow10.21B11.77B9.94B8.98B8.72B4.87B
Free Cash Flow Margin16.37%20.03%18.38%19.61%19.66%13.02%
Free Cash Flow Per Share6.547.536.365.755.593.41
Levered Free Cash Flow5.63B7.87B8.46B9.04B12.49B-1.85B
Unlevered Free Cash Flow6.40B8.58B9.22B9.60B12.84B-1.61B
Free Cash Flow After Leases9.83B11.39B9.62B8.72B8.47B4.63B
Cash Interest Paid1.39B1.32B1.31B1.08B849.00M721.00M
Cash Income Tax Paid3.29B2.85B2.75B2.37B1.62B1.74B
Change in Working Capital-2.93B-1.14B-893.00M300.00M3.76B2.02B

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization288.45B287.81B203.17B209.27B209.44B182.03B
Enterprise Value314.98B312.41B228.18B234.80B238.39B209.52B
Last Close Price186.58172.53125.08128.55130.24110.76
PE Ratio26.1728.1528.8835.1463.701,625.31
PS Ratio4.624.903.764.574.724.87
PB Ratio5.575.914.975.345.654.63
P/FCF Ratio28.2524.4620.4523.2924.0337.36
P/OCF Ratio21.8019.7517.1320.2321.3530.53
EV/Sales Ratio5.055.324.225.125.385.60
EV/EBITDA Ratio14.8016.2012.9916.4517.3431.27
EV/EBIT Ratio19.5721.8617.6524.2127.0572.32
EV/FCF Ratio30.8526.5522.9626.1427.3543.01
Debt / Equity Ratio0.660.610.740.760.840.85
Debt / EBITDA Ratio1.581.511.702.042.234.81
Debt / FCF Ratio3.362.523.063.303.576.85
Net Debt / Equity Ratio0.510.490.610.610.670.69
Net Debt / EBITDA Ratio1.231.241.421.671.814.02
Net Debt / FCF Ratio2.562.042.512.652.855.54
Asset Turnover0.530.540.530.460.440.43
Inventory Turnover1.691.811.801.591.261.85
Quick Ratio0.790.650.670.580.610.67
Current Ratio1.010.940.930.820.861.16
Return on Equity (ROE)22.57%22.84%17.59%15.64%8.63%0.42%
Return on Assets (ROA)8.58%8.19%7.88%6.13%5.46%2.10%
Return on Invested Capital (ROIC)17.15%17.03%16.27%13.42%13.75%6.00%
Return on Capital Employed (ROCE)18.20%17.10%17.00%13.70%12.60%3.50%
Earnings Yield3.82%3.55%3.46%2.85%1.57%0.06%
FCF Yield3.54%4.09%4.89%4.29%4.16%2.68%
Dividend Yield1.73%1.72%2.37%2.15%2.15%2.44%
Payout Ratio45.34%47.39%65.47%75.42%132.72%3,442.86%
Buyback Yield / Dilution0.02%0.06%-0.06%-0.13%-9.32%-8.68%
Total Shareholder Return1.75%1.79%2.30%2.02%-7.17%-6.24%